Search for: "Actavis Elizabeth, LLC " Results 1 - 20 of 44
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
When is the use of a product a “substantial noninfringing use” for purposes of Section 271(c)?
11 Dec 2023, 7:43 am by Holman
Actavis Elizabeth LLC). [read post]
Patently-O - https://patentlyo.com
Argentum's arguments for standing rejected by the CAFC in Gilenya case
24 Apr 2020, 5:24 am by Lawrence B. Ebert
., and Sun PharmaGlobal FZE’s (collectively, Sun); Teva PharmaceuticalsUSA, Inc. and Actavis Elizabeth LLC’s; and ArgentumPharmaceuticals LLC’s requests for joinder under 35U.S.C. [read post]
IPBiz - http://ipbiz.blogspot.com/
Judge Connolly Denies Orexo’s Motion for a New Trial in Hatch-Waxman Patent Action
13 Dec 2019, 8:15 am by Gregory B. Williams
Actavis Elizabeth LLC et al., Civil Action No. 17-205-CFC (D.Del. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Judge Connolly Denies Orexo’s Motion for a New Trial in Hatch-Waxman Patent Action
13 Dec 2019, 8:15 am by Gregory B. Williams
Actavis Elizabeth LLC et al., Civil Action No. 17-205-CFC (D.Del. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
Orexo AB v. Actavis Elizabeth LLC (Fed. Cir. 2018)
16 Sep 2018, 9:02 pm by Patent Docs
Actavis Elizabeth LLC handed down earlier this month. [read post]
Patent Docs - http://www.patentdocs.org/
Court Report
25 Aug 2016, 9:00 pm by Patent Docs
• Defendants: Actavis Elizabeth LLC; Actavis Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Court Report
5 Jun 2016, 9:39 pm by Patent Docs
• Defendants: Actavis Elizabeth LLC; Actavis Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Off-Label Use of Generic Drug Cannot Establish Existence of Noninfringing Uses
28 Aug 2014, 7:28 am by Docket Navigator
Actavis Elizabeth LLC et al, 3-12-cv-01358 (NJD August 25, 2014, Order) (Pisano, J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Triggering First ANDA Filer’s 180-Day Exclusivity Period Supports Declaratory Judgment Counterclaim of Noninfringement
11 Apr 2014, 7:15 am by Docket Navigator
Actavis Elizabeth LLC, 2-12-cv-05311 (NJD April 9, 2014, Order) (Linares, J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Pfizer v. Teva: Claimed Compound Not Limited to Racemic Mixture Thereof
28 Mar 2014, 5:33 pm
.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
Court Report
23 Jun 2013, 8:50 pm by Patent Docs
.; Actavis Elizabeth LLC; Actavis Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Weeks Reasoning – No Sweet Home In Alabama For Research Pharma
18 Jan 2013, 2:06 pm by Bexis
This post is by the Reed Smith part of the blog only. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Yet Another Reglan Lawsuit Added to California Mass Tort
16 Nov 2012, 2:30 am
., Actavis Elizabeth LLC and Pliva Inc., manufacturers of the generic equivalent of Reglan, as well as Schwartz Pharma. [read post]
Product Liability Attorney Blog - http://www.productliabilityattorneyblog.com/
Texas Two-step Thwarts Generic and Conte Claims/Conte Comes up Snake-eyes in Nevada
12 Sep 2012, 5:00 am by Steve McConnell
Actavis-Elizabeth LLC, 2012 U.S. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Actavis Will Pay $118.6 Million to End Drug-Pricing Claims
10 Jan 2012, 7:55 am by Dan Hargrove
  In February, a state court jury in Austin ordered units of the Iceland-based company to pay $170 million for inflating billings to the Texas Medicaid program.From the Texas Attorney General: Texas Attorney General Greg Abbott secured an $84 million agreement with pharmaceutical manufacturer Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC. [read post]
GovtFraudLawyer - http://www.govtfraudlawyer.blogspot.com/
FDA Approves Generic Equivalents of Kadian®
7 Dec 2011, 6:38 am by Medicare Set Aside Services
In November 2011, the FDA approved generic equivalents of the brand name product Kadian®, which is an extended-release morphine product manufactured by Actavis Elizabeth LLC. [read post]
The Official Medicare Blog and Information Resource - http://medicaresetasideblog.com
Pharma & Biotech Global Week in Review 17 August 2011 from IP Think Tank
16 Aug 2011, 11:35 pm by Marie Louise
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Eli Lilly & Co. v. Actavis Elizabeth LLC (Fed. Cir. 2011)
10 Aug 2011, 9:59 pm by Patent Docs
Activis Elizabeth LLC. [read post]
Patent Docs - http://www.patentdocs.org/
Lilly Wins Appeal Protecting Attention-Deficit Disorder Drug Patent
1 Aug 2011, 8:19 am
Actavis Elizabeth LLC et al, Case No. 2010-1500 in the Court of Appeals for the Federal Circuit, decided July 29, 2011. [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Pharma & Biotech Global Week in Review 29 June 2011 from IP Think Tank
29 Jun 2011, 3:34 am by Marie Louise
Mensing; Actavis Elizabeth, L.L.C. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog